1	Increased	increase	_	_	_	_	_	_	_
2	interleukin	interleukin	_	_	_	_	_	_	_
3	2	2	_	_	_	_	_	_	_
4	transcription	transcription	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	murine	murine	_	_	_	_	_	_	_
7	lymphocytes	lymphocyte	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	ciprofloxacin	ciprofloxacin	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	fluoroquinolone	fluoroquinolone	_	_	_	_	_	_	_
3	antibiotic	antibiotic	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	ciprofloxacin	ciprofloxacin	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	cipro	cipro	_	_	_	_	_	_	_
8	)	)	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	induces	induce	_	_	_	_	_	_	_
11	hyperproduction	hyperproduction	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	interleukin	interleukin	_	_	_	_	_	_	_
14	2	2	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	IL-2	il-2	_	_	_	_	_	_	_
17	)	)	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	interferon-gamma	interferon-gamma	_	_	_	_	_	_	_
20	(	(	_	_	_	_	_	_	_
21	IFN-gamma	IFN-gamma	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	stimulated	stimulate	_	_	_	_	_	_	_
25	human	human	_	_	_	_	_	_	_
26	peripheral	peripheral	_	_	_	_	_	_	_
27	blood	blood	_	_	_	_	_	_	_
28	lymphocytes	lymphocyte	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	investigation	investigation	_	_	_	_	_	_	_
4	an	an	_	_	_	_	_	_	_
5	enhanced	enhance	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	prolonged	prolong	_	_	_	_	_	_	_
8	IL-2	il-2	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	IL-2	il-2	_	_	_	_	_	_	_
11	mRNA	mrna	_	_	_	_	_	_	_
12	response	response	_	_	_	_	_	_	_
13	was	be	_	_	_	_	_	_	_
14	also	also	_	_	_	_	_	_	_
15	detected	detect	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	both	both	_	_	_	_	_	_	_
18	stimulated	stimulate	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	T	t	_	_	_	_	_	_	_
21	cell	cell	_	_	_	_	_	_	_
22	mitogens	mitogen	_	_	_	_	_	_	_
23	or	or	_	_	_	_	_	_	_
24	alloantigens	alloantigen	_	_	_	_	_	_	_
25	)	)	_	_	_	_	_	_	_
26	murine	murine	_	_	_	_	_	_	_
27	splenocytes	splenocyte	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	in	in	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	stimulated	stimulate	_	_	_	_	_	_	_
32	murine	murine	_	_	_	_	_	_	_
33	T	t	_	_	_	_	_	_	_
34	cell	cell	_	_	_	_	_	_	_
35	line	line	_	_	_	_	_	_	_
36	EL-4	el-4	_	_	_	_	_	_	_
37	in	in	_	_	_	_	_	_	_
38	the	the	_	_	_	_	_	_	_
39	presence	presence	_	_	_	_	_	_	_
40	of	of	_	_	_	_	_	_	_
41	ciprofloxacin	ciprofloxacin	_	_	_	_	_	_	_
42	(	(	_	_	_	_	_	_	_
43	5-80	5-80	_	_	_	_	_	_	_
44	micrograms/ml	micrograms/ml	_	_	_	_	_	_	_
45	)	)	_	_	_	_	_	_	_
46	as	as	_	_	_	_	_	_	_
47	compared	compare	_	_	_	_	_	_	_
48	to	to	_	_	_	_	_	_	_
49	control	control	_	_	_	_	_	_	_
50	cells	cell	_	_	_	_	_	_	_
51	without	without	_	_	_	_	_	_	_
52	antibiotics	antibiotic	_	_	_	_	_	_	_
53	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	contrast	contrast	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	human	human	_	_	_	_	_	_	_
7	lymphocytes	lymphocyte	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	IFN-gamma	IFN-gamma	_	_	_	_	_	_	_
10	production	production	_	_	_	_	_	_	_
11	was	be	_	_	_	_	_	_	_
12	inhibited	inhibit	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	IFN-gamma	IFN-gamma	_	_	_	_	_	_	_
15	mRNA	mRNA	_	_	_	_	_	_	_
16	levels	level	_	_	_	_	_	_	_
17	were	be	_	_	_	_	_	_	_
18	unaffected	unaffected	_	_	_	_	_	_	_
19	at	at	_	_	_	_	_	_	_
20	24	24	_	_	_	_	_	_	_
21	h	h	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	only	only	_	_	_	_	_	_	_
24	slightly	slightly	_	_	_	_	_	_	_
25	upregulated	upregulate	_	_	_	_	_	_	_
26	at	at	_	_	_	_	_	_	_
27	48	48	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	72	72	_	_	_	_	_	_	_
30	h	h	_	_	_	_	_	_	_
31	of	of	_	_	_	_	_	_	_
32	culture	culture	_	_	_	_	_	_	_
33	in	in	_	_	_	_	_	_	_
34	murine	murine	_	_	_	_	_	_	_
35	splenocytes	splenocyte	_	_	_	_	_	_	_
36	incubated	incubate	_	_	_	_	_	_	_
37	with	with	_	_	_	_	_	_	_
38	cipro	cipro	_	_	_	_	_	_	_
39	(	(	_	_	_	_	_	_	_
40	20	20	_	_	_	_	_	_	_
41	micrograms/ml	micrograms/ml	_	_	_	_	_	_	_
42	)	)	_	_	_	_	_	_	_
43	.	.	_	_	_	_	_	_	_

1	EL-4	el-4	_	_	_	_	_	_	_
2	cells	cell	_	_	_	_	_	_	_
3	were	be	_	_	_	_	_	_	_
4	transfected	transfecte	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	plasmid	plasmid	_	_	_	_	_	_	_
8	containing	contain	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	IL-2	il-2	_	_	_	_	_	_	_
11	promoter	promoter	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	enhancer	enhancer	_	_	_	_	_	_	_
14	region	region	_	_	_	_	_	_	_
15	linked	link	_	_	_	_	_	_	_
16	to	to	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	chloramphenicol	chloramphenicol	_	_	_	_	_	_	_
19	acetyltransferase	acetyltransferase	_	_	_	_	_	_	_
20	(	(	_	_	_	_	_	_	_
21	CAT	CAT	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	reporter	reporter	_	_	_	_	_	_	_
24	gene	gene	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	Analysis	Analysis	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	CAT	CAT	_	_	_	_	_	_	_
4	activity	activity	_	_	_	_	_	_	_
5	revealed	reveal	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	cipro	cipro	_	_	_	_	_	_	_
8	enhanced	enhance	_	_	_	_	_	_	_
9	IL-2	il-2	_	_	_	_	_	_	_
10	gene	gene	_	_	_	_	_	_	_
11	induction	induction	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	EL-4	el-4	_	_	_	_	_	_	_
5	cells	cell	_	_	_	_	_	_	_
6	incubated	incubate	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	ciprofloxacin	ciprofloxacin	_	_	_	_	_	_	_
9	showed	show	_	_	_	_	_	_	_
10	an	an	_	_	_	_	_	_	_
11	early	early	_	_	_	_	_	_	_
12	peak	peak	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	more	more	_	_	_	_	_	_	_
15	activated	activate	_	_	_	_	_	_	_
16	nuclear	nuclear	_	_	_	_	_	_	_
17	factor	factor	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	activated	activate	_	_	_	_	_	_	_
20	T	t	_	_	_	_	_	_	_
21	cells	cell	_	_	_	_	_	_	_
22	(	(	_	_	_	_	_	_	_
23	NFAT-1	nfat-1	_	_	_	_	_	_	_
24	)	)	_	_	_	_	_	_	_
25	as	as	_	_	_	_	_	_	_
26	compared	compare	_	_	_	_	_	_	_
27	to	to	_	_	_	_	_	_	_
28	control	control	_	_	_	_	_	_	_
29	cells	cell	_	_	_	_	_	_	_
30	without	without	_	_	_	_	_	_	_
31	antibiotics	antibiotic	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	Cipro	Cipro	_	_	_	_	_	_	_
2	did	do	_	_	_	_	_	_	_
3	not	not	_	_	_	_	_	_	_
4	affect	affect	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	nuclear	nuclear	_	_	_	_	_	_	_
7	transcription	transcription	_	_	_	_	_	_	_
8	factors	factor	_	_	_	_	_	_	_
9	AP-1	ap-1	_	_	_	_	_	_	_
10	or	or	_	_	_	_	_	_	_
11	NFIL-2A.	NFIL-2A.	_	_	_	_	_	_	_
12	Taken	take	_	_	_	_	_	_	_
13	together	together	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	cipro	cipro	_	_	_	_	_	_	_
16	inhibited	inhibit	_	_	_	_	_	_	_
17	IFN-gamma	IFN-gamma	_	_	_	_	_	_	_
18	synthesis	synthesis	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	but	but	_	_	_	_	_	_	_
21	enhanced	enhance	_	_	_	_	_	_	_
22	IL-2	il-2	_	_	_	_	_	_	_
23	production	production	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	murine	murine	_	_	_	_	_	_	_
26	lymphocytes	lymphocyte	_	_	_	_	_	_	_
27	by	by	_	_	_	_	_	_	_
28	means	mean	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	influencing	influence	_	_	_	_	_	_	_
31	NFAT-1	nfat-1	_	_	_	_	_	_	_
32	and	and	_	_	_	_	_	_	_
33	causing	cause	_	_	_	_	_	_	_
34	an	an	_	_	_	_	_	_	_
35	increased	increase	_	_	_	_	_	_	_
36	IL-2	il-2	_	_	_	_	_	_	_
37	transcription	transcription	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

